Data as of Dec 06
| -0.25 / -6.93%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +123.21% increase from the last price of 3.36.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.